Rep. April McClain Delaney Buys Shares of BWX Technologies, Inc. (NYSE:BWXT)

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on August 03rd, the Representative disclosed that they had bought between $1,001 and $15,000 in BWX Technologies stock on July 27th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Life Time Group (NYSE:LTH) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 7/31/2026.
• Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 7/31/2026.
• Sold $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of Somnigroup International (NYSE:SGI) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of Life Time Group (NYSE:LTH) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Service Corporation International (NYSE:SCI) on 7/30/2026.

BWX Technologies Stock Performance

BWXT stock traded down $1.70 on Wednesday, hitting $170.70. The company’s stock had a trading volume of 164,891 shares, compared to its average volume of 1,016,150. The firm has a 50 day moving average of $186.82 and a two-hundred day moving average of $201.30. BWX Technologies, Inc. has a 1 year low of $157.10 and a 1 year high of $241.82. The stock has a market cap of $15.64 billion, a price-to-earnings ratio of 45.64, a price-to-earnings-growth ratio of 2.96 and a beta of 0.76. The company has a current ratio of 2.40, a quick ratio of 2.33 and a debt-to-equity ratio of 1.58.

BWX Technologies (NYSE:BWXT) last issued its quarterly earnings data on Monday, August 3rd. The technology company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.03. BWX Technologies had a net margin of 10.11% and a return on equity of 31.34%. The company had revenue of $901.62 million for the quarter, compared to the consensus estimate of $902.41 million. During the same period last year, the firm posted $1.02 EPS. BWX Technologies’s revenue for the quarter was up 18.0% on a year-over-year basis. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Equities analysts predict that BWX Technologies, Inc. will post 4.61 EPS for the current fiscal year.

BWX Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Tuesday, August 18th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, August 18th. BWX Technologies’s payout ratio is presently 28.88%.

Insider Buying and Selling

In other news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the sale, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at $41,472,181.71. This trade represents a 4.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $209.25, for a total transaction of $505,757.25. Following the completion of the sale, the chief financial officer owned 6,884 shares of the company’s stock, valued at $1,440,477. This represents a 25.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

BWX Technologies News Summary

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: Strong quarterly results: BWXT reported second-quarter EPS of $1.07, exceeding the $1.04 analyst consensus, while revenue rose 18% year over year to approximately $901.6 million. Commercial operations revenue increased 72% to $302.5 million. BWX Technologies Reports Second Quarter 2026 Results
• Positive Sentiment: Higher 2026 outlook and cash flow: Management raised full-year 2026 adjusted EPS guidance to $4.70-$4.80 and free cash flow guidance to $345 million-$360 million. The company cited strong execution, operating performance and growing nuclear demand. BWXT targets higher EPS and free cash flow outlook
• Positive Sentiment: Strategic medical-business sale: BWXT agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million, while retaining a minority stake. Proceeds should provide capital for commercial nuclear, small modular reactor and defense-related expansion, sharpening BWXT’s focus on nuclear markets. BWXT Selling Medical Business to Nordic Capital
• Positive Sentiment: Supportive analyst view: BTIG reaffirmed its Buy rating and $235 price target. Northland Securities raised its FY2026 EPS forecast to $4.71 from $4.68 and FY2027 to $5.17 from $5.11, above the current-year consensus estimate of $4.61.
• Neutral Sentiment: BWXT maintained its quarterly dividend at $0.27 per share, payable September 4 to shareholders of record August 18. The dividend offers a modest yield of approximately 0.6%.
• Negative Sentiment: Northland lowered its Q3 2026 EPS estimate to $1.18 from $1.22, suggesting some softness in the next quarter despite higher full-year and 2027 projections. BWXT also trades at a relatively elevated earnings multiple, which may increase sensitivity to execution or broader market rotation.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Weiss Ratings cut BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, July 29th. Zacks Research cut shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. JPMorgan Chase & Co. started coverage on shares of BWX Technologies in a report on Monday, July 27th. They issued an “overweight” rating and a $230.00 target price on the stock. Seaport Research Partners raised shares of BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price target for the company in a report on Monday, June 22nd. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of BWX Technologies from a “hold” rating to a “buy” rating and raised their price objective for the company from $205.00 to $255.00 in a research report on Friday, May 15th. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $228.20.

Institutional Trading of BWX Technologies

Institutional investors and hedge funds have recently modified their holdings of the business. WFA of San Diego LLC acquired a new position in shares of BWX Technologies during the 2nd quarter worth approximately $29,000. MV Capital Management Inc. acquired a new stake in shares of BWX Technologies in the fourth quarter worth approximately $32,000. Tucker Asset Management LLC purchased a new position in shares of BWX Technologies in the 4th quarter valued at $36,000. Vermillion Wealth Management Inc. boosted its position in BWX Technologies by 71.7% in the 4th quarter. Vermillion Wealth Management Inc. now owns 237 shares of the technology company’s stock valued at $41,000 after buying an additional 99 shares during the last quarter. Finally, Smithfield Trust Co lifted its position in shares of BWX Technologies by 52.1% during the fourth quarter. Smithfield Trust Co now owns 251 shares of the technology company’s stock worth $44,000 after purchasing an additional 86 shares during the last quarter. Hedge funds and other institutional investors own 94.39% of the company’s stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.